No Results
"We are currently gathering more data to assess the safety of supernus.com. Your safety is our priority, and we're conducting a thorough analysis before providing a comprehensive evaluation."
Supernus, a specialty pharmaceutical company with more than 25 years of experience focused on developing products to treat central nervous system diseases.
Traffic rank of supernus.com, compared to all other sites
↓ 1.81M+
United States
Website ranking is crucial for evaluating supernus.com's stats. TopWeb.ai leverages cutting-edge techniques, including data gathering, collection, and analysis from diverse internet resources, to estimate website traffic. Our assessments are based solely on publicly available information, offering valuable insights into potential traffic trends without relying on business owner-provided data. Additionally, we utilize advanced tools like ChatGPT and Gemini API to enhance our evaluation process, ensuring accurate and comprehensive traffic estimations and analysis.
Over the last three months, supernus.com's global ranking has decreased from 490,247 to 2,295,341.
Total Visits
Bounce Rate
Pages per Visit
Avg Visit Duration
Moz metrics are by Moz that predicts how well a specific page will rank.
WOT's security score derives from our partners and community-driven expert reviews
Amazon Alexa Rank provides a broad gauge of a website's online popularity.
The Organic Search section reveals valuable insights, including organic traffic and keywords for in Google's top 100 search results.
Explore alternative, competitive and similar websites to supernus.com based on traffic, content and site structure.
Anthera alternatives
Learn how Oxtellar XR® extended-release tablets are designed to help people living with partial-onset seizures. See Full Prescribing & Safety Information.
Oxtellarxr alternatives
Learn about Oxtellar XR® (oxcarbazepine), an adjunctive therapy for patients with partial-onset seizures. See Prescribing & Safety Information.
Oxtellarxrhcp alternatives
Topamax alternatives
Learn about Trokendi XR® (topiramate), a migraine prevention medicine for adults and children ages 12 years of age and older. See Full Prescribing & Safety Info.
Trokendixr alternatives
Learn about Trokendi XR® (topiramate), a 24-hour migraine prevention medication designed and approved for QD dosing. See Full Prescribing & Safety Information.
Trokendixrhcp alternatives
Cortellis - Clarivate Analytics.
Cortellis alternatives
Unryudo alternatives
BeiGene is a biopharmaceutical company focused on developing molecularly targeted and immuno-oncology drug candidates for the treatment of cancer.
Beigene alternatives
Pharmchoices alternatives
Check out some of our popular sites.